A bill to amend the Public Health Service Act with respect to...
A bill to amend the Public Health Service Act with respect to the drug discount program, and for other purposes.
This bill aims to modify the Public Health Service Act, focusing on the drug discount program. It seeks to make prescription drugs more affordable for consumers, particularly those without insurance or with high deductibles. The bill targets pharmaceutical companies and insurance providers to ensure they offer fair pricing for medications.
The changes would primarily affect consumers who rely on prescription drugs, especially those who pay out of pocket or have limited insurance coverage. It could also impact pharmaceutical companies and insurance companies by imposing stricter regulations on drug pricing and discounts. This may lead to lower prices for consumers and potentially affect the pricing strategies of drug manufacturers.
As of August 5, 2026, the bill has been introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions. Key steps include its introduction and referral to committee, where it will undergo further review and potential amendments before any vote by the full Senate.
